By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births.

3.1.1: Maternal mortality ratio.

3.1.2: Proportion of births attended by skilled health personnel.

The global maternal mortality ratio marginally declined from 227 maternal deaths per 100,000 live births in 2015 to 223 in 2020. Reaching the global maternal mortality rate target of 70 per 100,00 live births will require an annual rate of reduction of 11.6% between 2021 and 2030. Two regions, subSaharan Africa and Southern Asia, accounted for around 87% (249,000) of the estimated global maternal deaths in 2020. Globally, skilled birth attendance rose from 80% in 2015 to 86% in 2023. There are, however, significant regional disparities, particularly in sub-Saharan Africa where the rate was just 73% in 2023.

By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births.

3.2.1: Under-five mortality rate.

3.2.2: Neonatal mortality rate.

In 2022, global under-five deaths was 4.9 million, down from 9.9 million in 2000 and 6.0 million in 2015. The under-five mortality rate fell to 37 deaths per 1,000 live births in 2022—51% lower than in 2000 and a 14% decline since 2015. Similarly, the global neonatal mortality rate fell to 17 deaths per 1,000 live births in 2022, a 44% and 12% decrease from the 2000 and 2015 levels, respectively.

By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases.

3.3.1: Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations.

3.3.2: Tuberculosis incidence per 100,000 population.

3.3.3: Malaria incidence per 1,000 population.

3.3.4: Hepatitis B incidence per 100,000 population.

3.3.5: Number of people requiring interventions against neglected tropical diseases.

Mixed progress is observed towards the SDG target of ending communicable diseases a). There were an estimated 1.3 million new HIV infections in 2022, 27% fewer than in 2015, and 38% fewer than in 2010. Increased access to HIV treatment has averted almost 20.8 million AIDS-related deaths in the past three decades. b). The reported global number of people newly diagnosed with TB was 7.5 million in 2022, the highest since 1995. On the other hand, the annual number of people who died from TB decreased in 2022 after two consecutive years of increase due to COVID-19 pandemic. c). In 2022, there were an estimated 249 million malaria cases globally, exceeding the pre-pandemic level of 233 million in 2019. d). In 2022, 1.62 billion people required interventions and care for neglected tropical diseases (NTDs), a 26.1% of decline from 2010. As of December 2023, 50 countries, territories and areas have eliminated at least one NTD.

By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.

3.4.1: Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease.

3.4.2: Suicide mortality rate.

No summary information is available at this time.

Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol.

3.5.1: Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders.

3.5.2: Alcohol per capita consumption (aged 15 years and older) within a calendar year in litres of pure alcohol.

Global drug-related treatment coverage has decreased from approximately 11% in 2015 to under 9% in 2022. Alarmingly, treatment coverage for women consistently lags behind that for men across all regions. In 2022, over 13% of men with drug use disorders received treatment globally, while less than 6% of women did. Moreover, data on treatment coverage for alcohol use disorders vary widely, ranging from a mere 0.3% to a maximum of 14% in reporting countries.

By 2020, halve the number of global deaths and injuries from road traffic accidents.

3.6.1: Death rate due to road traffic injuries.

While most SDG targets are set for 2030, this was set to be achieved for 2020. Note that the SDG Indicator is the rate of road deaths while the target is set for the absolute number of road deaths. Data is provided in chart 3.6.1.

By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes.

3.7.1: Proportion of women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods.

3.7.2: Adolescent birth rate (aged 10-14 years; aged 15-19 years) per 1,000 women in that age group.

The proportion of women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods increased slightly from 76.5% to 77.6% between 2015 and 2024. This corresponds to an increase of 75 million women of reproductive age using modern methods since 2015. The adolescent birth rate has globally declined from 47.2 births per 1,000 girls and women aged 15 to 19 years in 2015 to 40.7 in 2024.

Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.

3.8.1: Coverage of essential health services.

3.8.2: Proportion of population with large household expenditures on health as a share of total household expenditure or income.

The proportion of the population not covered by essential health services decreased by about 15% between 2000 and 2021, with minimal progress made after 2015. In 2021, about four and a half billion people were not covered by essential health services.

By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination.

3.9.1: Mortality rate attributed to household and ambient air pollution.

3.9.2: Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (exposure to unsafe Water, Sanitation and Hygiene for All (WASH) services).

3.9.3: Mortality rate attributed to unintentional poisoning.

Indicator 3.9.1. is measured as the number of deaths attributed to indoor and outdoor air pollution per 100,000 people, accounting for differences in the age structure of different populations. Data for this indicator is shown in the series of interactive visualisations, first for household and ambient air pollution combined, then for each separately, and then with a comparison of the two types of pollution in the final chart.

Indicator 3.9.2 is defined as the number of deaths per 100,000 people that are attributed to unsafe water, unsafe sanitation, and lack of hygiene (defined as exposure to unsafe Water, Sanitation, and Hygiene for All (WASH) services). This definition includes deaths from diarrhoea, intestinal nematode infections, malnutrition and acute respiratory infections.

Indicator 3.9.3. measures the annual number of deaths per 100,000 people that are attributed to unintentional poisonings.

Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate.

3.A.1: Age-standardised prevalence of current tobacco use among persons aged 15 years and older.

In 2022, the global prevalence of current tobacco use among the population aged 15+ was estimated at 20.9%. This translates to around 1.25 billion adult tobacco users in the world. The prevalence has declined since 2015 when it was 23.9%, and the number of users has decreased by 50 million.

Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all.

3.B.1: Proportion of the target population covered by all vaccines included in their national programme.

3.B.2: Total net official development assistance to medical research and basic health sectors.

3.B.3: Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis.

Coverage of the third dose of vaccine protecting against diphtheria, tetanus, and pertussis (DTP-3) recovered to 84% in 2022, an improvement from 81% in 2021 but still below the 2019 level of 86%. In 2022, 20.5 million children remained vulnerable to vaccine-preventable diseases. The current 2-dose measles vaccine coverage of 74% is insufficient to prevent outbreaks. HPV vaccine declined significantly during the pandemic, but 2022 saw the first encouraging signs of recovery in vaccination with 15% full scheduled coverage among girls.